SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006396
Filing Date
2024-11-12
Accepted
2024-11-12 09:31:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 LEXEO THERAPEUTICS, INC. p24-3090sc13g.htm SC 13G 61554
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p24-3090exhibit99.htm EX-99.1 3529
  Complete submission text file 0000902664-24-006396.txt   66652
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Subject) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94231 | Film No.: 241444184
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)